JBJS | Familial Heterozygous Protein-S Deficiency in a Patient Who Had Multifocal Osteonecrosis. A Case Report*

The Journal of Bone & Joint Surgery, Volume 79, Issue 7

Case Reports | July 01, 1997

Familial Heterozygous Protein-S Deficiency in a Patient Who Had Multifocal Osteonecrosis. A Case Report*

HENRI PIERRE-JACQUES, M.D.†, BALTIMORE; CHARLES J. GLUECK, M.D.‡, CINCINNATI, OHIO; MICHAEL A. MONT, M.D.†; DAVID S. HUNGERFORD, M.D.†, BALTIMORE, MARYLAND

View Disclosures and Other Information

Investigation performed at Good Samaritan Hospital, Baltimore, and Jewish Hospital, Cincinnati

The Journal of Bone & Joint Surgery. 1997; 79:1079-84

5 Recommendations (Recommend) | 3 Comments | Saved by 3 Users Save Case

Article

Figures

References

text A A A

Introduction

Introduction | Case Report | Discussion | References

Osteonecrosis that is associated with the use of drugs such as corticosteroids^{14,24,32,35,39} or with underlying disease processes^36,45,48,49 such as alcohol abuse³⁹ has been characterized as secondary. Despite extensive investigations of the demographic characteristics of patients who have osteonecrosis^32,35,39, as many as 39.5 per cent of these patients (934 of 2364 in one study³⁹) have had no known risk factors, and the osteonecrosis has been characterized as idiopathic. However, as one of us (C. J. G.) and colleagues^{16-19,21-24,27} as well as others^5,28,37,46 have shown, many instances of osteonecrosis that previously would have been regarded as idiopathic actually were associated with heritable thrombophilia (an increased tendency for intravascular thrombosis) and hypofibrinolysis (a reduced ability to lyse thrombi).

The association between coagulation abnormalities and osteonecrosis has been recognized for more than thirty-five years^2,28,37,41, but it has not been studied extensively, to our knowledge. Recent studies by one of us (C. J. G.) and colleagues^16-24,27 and by others^5,28,37,46 have redirected attention to this area. This association has major implications not only for the diagnosis and treatment of osteonecrosis but also for the screening of the relatives of affected individuals and the possible prevention of this and other thrombotic and thromboembolic disorders in those who are found to be at increased risk because of inherited thrombophilia or hypofibrinolysis^{17,18,21,22,24}.

We report the case of a patient in whom multifocal osteonecrosis was found to be associated with familial heterozygous protein-S deficiency, a thrombophilic disorder. To our knowledge, this is the first report in which a protein deficiency was found to be associated with osteonecrosis of the hip in an adult, although such deficiencies have been associated with Perthes disease^18,22 and osteonecrosis of the jaw^21,27. The purpose of the present report is to bring to the attention of the orthopaedic community the association between osteonecrosis and protein-S deficiency in this family.

* No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article. No funds were received in support of this study.

† Department of Orthopaedic Surgery, Good Samaritan Hospital, Professional Office Building, 5601 Loch Raven Boulevard, Baltimore, Maryland 21239. E-mail address: rhondamont@aol.com (Dr. Mont.)

‡ Cholesterol Center, Jewish Hospital, 3200 Burnet Avenue, Cincinnati, Ohio 45229. E-mail address: glueckch@wealthall.com (Dr. Glueck).

† Department of Orthopaedic Surgery, Good Samaritan Hospital, Professional Office Building, 5601 Loch Raven Boulevard, Baltimore, Maryland 21239. E-mail address: rhondamont@aol.com (Dr. Mont.)

‡ Cholesterol Center, Jewish Hospital, 3200 Burnet Avenue, Cincinnati, Ohio 45229. E-mail address: glueckch@wealthall.com (Dr. Glueck).

View Large | Download Slide(.ppt)
Add to My JBJS

Figs. 1-A and 1-B: Diagnostic studies demonstrating bilateral osteonecrosis of the hip. Fig. 1-A: Anteroposterior radiograph of the pelvis showing changes indicative of Ficat stage-III disease^14,15 of both hips, including crescent signs (arrows) and minimum collapse of the femoral head.

View Large | Download Slide(.ppt)
Add to My JBJS

Fig. 1-B T1-weighted magnetic resonance image of both hips, showing decreased signal intensity outlining the lesions (arrows).

View Large | Download Slide(.ppt)
Add to My JBJS

Fig. 2 T1-weighted sagittal magnetic resonance image of the right knee, showing areas of decreased signal intensity outlining the lesions of the distal part of the femur (arrows) as well as the proximal part of the tibia (arrow).

View Large | Download Slide(.ppt)
Add to My JBJS

Fig. 3 Levels of total antigenic protein S (S[ag]), free protein S, functional protein S, and C4b-binding protein (compared with the fifth to ninety-fifth percentile range for normal controls¹⁸) in the proband (II-7), her siblings (II-1 through II-6), and her children (III-1 and III-2).

Case Report

Introduction | Case Report | Discussion | References

A twenty-eight-year-old woman was seen because of a two-year history of pain in both shoulders, hips, and knees, as well as in the left ankle and foot, that had limited the activities of daily living. She was otherwise healthy and had no history of alcohol abuse, corticosteroid use, or other risk factors known to be associated with osteonecrosis. She was not taking birth control pills. The family history revealed that an uncle had died suddenly, presumably secondary to a pulmonary embolus.

On musculoskeletal examination, she had a mildly antalgic gait on the left. In addition, she had bilateral pain in the groin as well as pain in the left foot and ankle with walking, mild discomfort in the shoulders with abduction and forward elevation, and moderate bilateral discomfort in the groin with any internal rotation of the hips. There was no notable limitation of motion except for that secondary to pain. Both knees had a full range of motion, complete ligamentous stability, and no effusion. Both ankles had a full range of motion, with pain of the left foot and ankle occurring only during walking.

Plain radiographs of the shoulders revealed bilaterally symmetrical sclerotic lesions in the superomedial portions of both humeral heads without any subchondral radiolucency or irregularities of the joint surface. Magnetic resonance images demonstrated abnormalities in the same location; these findings were considered to be consistent with osteonecrosis. T2-weighted magnetic resonance images demonstrated a double-line sign³⁵ (a band of increased signal intensity surrounded by a band of decreased signal intensity), which is considered pathognomonic of osteonecrosis. As there were no areas of collapse, these lesions were considered to be consistent with Ficat stage-II osteonecrosis^14,15. Anteroposterior radiographs of the pelvis (Fig. 1-A) and frog-leg lateral radiographs of the hips showed a mottled pattern of increased radiodensity that emanated from the centers of the femoral heads and extended out to the articular surfaces, encompassing an arc of 120 degrees. Both hips had subchondral radiolucent areas with less than two millimeters of depression of the femoral head, findings that were consistent with Ficat stage-III involvement^14,15. There was no involvement of the acetabulum or loss of the articular cartilage space. A 25-degree lateral margin of uninvolved bone, consistent with that noted in association with a medial or an Ohzono type-B lesion³⁸, was observed in both hips. Magnetic resonance images showed lesions that encompassed approximately 50 per cent of the weight-bearing surfaces of both femoral heads (Fig. 1-B). Both hips had small effusions in the joint. Radiographs of both knees revealed normal findings. However, magnetic resonance images showed extensive involvement of both femoral condyles as well as both tibial plateaus (Fig. 2). Radiographs and magnetic resonance images of the left ankle and foot showed a small area of involvement in the proximal-lateral corner of the talus; the lesion appeared to be consistent with osteochondritis dissecans. The main body of the talus was not affected. However, the cuneiforms appeared to have extensive areas of osteonecrosis.

After the patient had fasted overnight, blood was obtained for the assessment of thrombophilia (as indicated by the levels of protein C, protein S, and anticardiolipin antibodies as well as by the resistance to activated protein C) and hypofibrinolysis (as indicated by the levels of lipoprotein[a] as well as by basal plasminogen activator-inhibitor activity and stimulated tissue-plasminogen activator activity) according to previously described techniques^18,21,24,27. Measurements of fibrinolytic activity were normal: the level of lipoprotein(a) was ten milligrams per deciliter (normal, less than twenty-five milligrams per deciliter), basal plasminogen activator-inhibitor activity was 7.4 units per milliliter (normal, less than 26.9 units per milliliter), and stimulated tissue-plasminogen activator activity was 3.9 international units per milliliter (normal, more than 2.28 international units per milliliter). Most of the measurements of thrombophilia were normal: the resistance to activated protein C was 3.4 (normal, more than 2.0), the level of protein C was 92 per cent (normal, more than 70 per cent), the level of anticardiolipin IgG was sixteen units (normal, less than twenty-two units), and the level of anticardiolipin IgM was nine units (normal, less than ten units). The blood-chemistry profile, the hematocrit and the level of hemoglobin, the sickle-cell preparation, the erythrocyte sedimentation rate, and the lipid profile all were normal as well.

When the initial sampling revealed that the patient had protein-S deficiency, and the results of other tests of coagulation were normal, the subsequent sampling of family members focused on protein S. None of the individuals tested were taking birth control pills, which have been associated with low levels of protein S¹⁶. The levels of total antigenic protein S and free protein S in the proband and in her first-degree relatives were compared with the values in the fifth to ninety-fifth percentile for sixty normal adults¹⁸, and the levels of functional protein S and C₄b-binding protein were compared with the values in the fifth to ninety-fifth percentile for thirty normal adults¹⁸ (Fig. 3). With use of these cutoff points, the likelihood that the total, free, and functional protein-S levels of the proband were, by chance, below the fifth percentile for the normal controls was less than 5 per cent (p <0.05), a conventional marker of significance. Similarly, the fifth percentile for total protein S in thirty normal children¹⁸ was 76 per cent, and the likelihood that the level of total protein S of the proband's daughter was below this level by chance was less than 5 per cent. Because the proband and her family lived more than 7000 miles (11,265 kilometers) from our laboratory and all frozen samples of plasma had to be shipped by air, duplicate protein-S measurements were made only in the proband, in her daughter and son, and in a male sibling (Fig. 3).

Levels of total antigenic, free, and functional protein S and the level of C₄b-binding protein were measured in two separate samples drawn from the proband, eight days apart (II-7, Fig. 3). Total antigenic protein-S levels also were measured in two separate samples from her protein S-deficient daughter and sister and from her normal son (III-1, II-4, and III-3, Fig. 3). In the proband, the total antigenic, free, and functional protein-S levels were below the fifth percentile for the normal controls (p <0.05). In the proband's daughter, the total antigenic protein-S level (60 and 55 per cent, as measured in two separate samples) was well below the fifth percentile (76 per cent¹⁸) for the normal pediatric controls (p < 0.05). The proband's daughter had a very low level of C₄b-binding protein, which in turn may have exaggerated the level of free protein S⁶. The proband's affected sister, like the proband, had low total antigenic protein-S, free protein-S, and functional protein-S levels, all below the fifth percentile for the normal controls (p < 0.05 for all three levels).

The proband's six normal first-degree relatives had predominantly normal total antigenic protein-S, free protein-S, and C₄b-binding protein levels, within the fifth to ninety-fifth percentiles for the normal controls (Fig. 3).

Alternative therapeutic modalities were reviewed with the patient. Core decompressions of both shoulders, hips, and knees were performed without complications. Histological analysis of all intraoperative specimens confirmed the diagnosis of osteonecrosis. Postoperatively, the patient participated in a program of physical therapy, walked with crutches and a four-point gait, and used a wheelchair for long distances; after six weeks, she progressed to full weight-bearing without restrictions. Anticoagulation therapy consisting of intravenous administration of heparin with conversion to oral administration of Coumadin (warfarin) also was initiated immediately postoperatively, and the dose was adjusted to maintain an international normalized ratio of 2.0 to 2.5.

Discussion

Introduction | Case Report | Discussion | References

There has been no consensus regarding the major pathophysiological mechanisms of osteonecrosis. Multiple theories have been advanced, with infarction³⁵, fat embolism^32,33, progressive ischemia^30,31,47, and accumulative cell stress³⁵ being suggested as mechanisms. Although the pathogenesis of idiopathic osteonecrosis remains to be fully explained, previous studies have demonstrated that coagulation disorders and thrombotic events may be pathogenic^{2,5,16-19,21-24,27,28,37,46}. Jones^32,33 reported that intravascular coagulation with fibrin-platelet thrombosis beginning in the vulnerable subchondral microcirculation (the capillary and sinusoidal bed) was especially associated with vasoconstriction and impaired secondary fibrinolysis (reperfusion of necrotic vessels with peripheral marrow hemorrhages) and that this appeared to be the final common pathway producing non-traumatic osteonecrosis. One of us (C. J. G.) and colleagues^16-24,27 as well as others^42,43, in published series of adults who had osteonecrosis of the hip or jaw and children who had Perthes disease, provided additional evidence to support this theory; in one study¹⁷, 220 (76 per cent) of 289 patients who had osteonecrosis were found to have thrombophilia or hypofibrinolysis, or both, primarily as autosomal dominant, highly penetrant heritable traits.

Previous studies of children and adults who had osteonecrosis of the hip and adults who had osteonecrosis of the jaw have suggested that thrombophilia and hypofibrinolysis facilitate venous occlusion of the bone by fibrinous clots, leading to venous or sinusoidal hypertension within the cancellous bone^{17-19,21-24,27,34}. Once the ischemic threshold is reached, cellular hypoxia presumably gives way to death of bone and marrow cells^{5,17-19,21-24,27}.

The detection of thrombophilia or hypofibrinolysis, or both, in 220 (76 per cent) of 289 patients who had osteonecrosis¹⁷ has substantial ramifications for the diagnosis and treatment of osteonecrosis as well as for the screening of family members and the prevention of thrombotic and thromboembolic events in those who are found to be at risk. These hypercoagulable states are predominantly inherited but also may be acquired^{16-19,21-24,27}. The inherited disorders include deficiencies of specific protein inhibitors of the coagulation cascade (such as protein C, protein S, and structural abnormalities of factor V [resistance to activated protein C]³) and disorders of the fibrinolytic system (such as impaired release of tissue-plasminogen activator activity, increased levels of plasminogen activator-inhibitor, and high levels of lipoprotein[a]). Although predominantly inherited as autosomal dominant traits, these disorders also can occur de novo as a result of gene mutation²⁶.

There is also evidence that acquired coagulation disorders, when superimposed on underlying heritable disorders, can increase the likelihood of thrombosis synergistically^21,23,27. One of us (C. J. G.) and colleagues demonstrated that exogenous estrogen supplementation (which by itself may induce resistance to activated protein C) synergistically increased the severity of osteonecrosis of the jaw in women who had underlying heritable resistance to activated protein C^21,23,27.

Familial protein-S deficiency was the only coagulation abnormality found in our patient, who had multifocal idiopathic osteonecrosis. She had no diseases that are associated with secondary osteonecrosis and was not taking medications that have been associated with that condition. Protein S is a vitamin K-dependent, antithrombotic plasma protein that serves as a cofactor for another antithrombotic plasma protein, protein C. Once activated, protein C inhibits the coagulation cascade by enzymatic cleavage of the activated forms of clotting factors V and VIII. Approximately 60 per cent of protein S is reversibly bound to C₄b-binding protein and 40 per cent is free; when the concentration of C₄b-binding protein increases the level of free protein S decreases, and when the concentration of C₄b-binding protein decreases the level of free protein S increases⁶. Only the free form of protein S functions as a cofactor for activated protein C. Protein-S deficiency has been diagnosed on the basis of a reduction in the total antigenic protein-S level or a reduction in the free protein-S level with a low or below-normal total protein-S level⁶; both diagnostic criteria were met by the three affected family members in the present study (p < 0.05) (Fig. 3). The proband's daughter had low total protein-S levels (60 and 55 per cent) as well as a very low level of C₄b-binding protein (58 per cent). The functional protein-S level was normal in the proband's daughter, probably because of the relatively high proportion of total protein S that was free, as the functional protein-S level reflects the free protein-S level and is based on enhancement of the anticoagulant effect of exogenous activated protein C by free protein S in the plasma⁸.

One of us (C. J. G.) and colleagues recently reported that protein-S deficiency was detected in zero of thirty-one adults who had osteonecrosis¹⁷, in three (2.9 per cent) of 104 patients who had osteonecrosis of the jaw^21,27, and in five (9.6 per cent) of fifty-two children who had Perthes disease^18,22. The disorder was shown to be familial in two of the five kindreds in the latter two studies^18,22.

Deficiency of protein S has been associated with an increased tendency toward thrombosis^{1,4,7,9-13,29,40,42}. This disorder is inherited as an autosomal dominant trait, with heterozygous individuals usually having plasma levels that are approximately one-half of the values in normal controls^4,7. In the present report, two of the eight asymptomatic first-degree relatives of the proband (her six-year-old daughter and her thirty-two year-old sister) were found to have deficiencies of protein S and free protein S. In addition, the proband's uncle had died of a probable pulmonary embolus. In view of the inheritance pattern of these coagulation disorders (all of which are highly penetrant, autosomal dominant traits), we recommend the screening of all first-degree relatives of patients who have proved coagulation deficiencies. The prevalence of protein-S deficiency has been reported to be 8 per cent among patients who have thrombotic events before the age of forty years or who have a family history of thrombosis^13,25.

Our limited, non-blinded experience with eight patients^16,17,19 suggests that it may be possible to retard or reverse the osteonecrotic process by correcting underlying coagulation disorders (such as thrombophilia and hypofibrinolysis) with use of stanozolol or Coumadin (warfarin). Such therapy needs to be initiated in the early stages of osteonecrosis (Ficat stage I or II^14,15)^16,17,19, before irreversible segmental collapse of the head of the femur occurs. Correction of thrombophilia or hypofibrinolysis may allow for the recovery of venous drainage and the reduction of intramedullary venous hypertension, thereby leading to normal oxygenation of bone and reversal of the ischemic necrosis of bone^16,17,19.

To our knowledge, this is the first report in which a protein-S deficiency was found to be associated with osteonecrosis of the hip in an adult. As this deficiency, as well as others in the coagulation pathway, recently was identified in 220 (76 per cent) of 289 patients who had osteonecrosis¹⁷, we believe that the systematic evaluation of coagulation and fibrinolysis is indicated for all patients who have osteonecrosis. Careful screening of the first-degree relatives of these patients also is indicated. The diagnosis of coagulation disorders may affect not only the diagnosis, treatment, and prevention of both idiopathic and secondary osteonecrosis but also the prevention of thrombotic and thromboembolic events in affected first-degree relatives. Advances in genetic mapping and engineering may allow for targeted treatment with manufacture of deficient proteins, with use of recombinant gene techniques.

Because the associations between thrombophilic and hypofibrinolytic disorders and osteonecrosis of the jaw and the hip have been recognized only recently, there are as yet no data from placebo-controlled, blinded studies to indicate whether the treatment of such coagulation abnormalities has an effect on osteonecrosis. We have initiated such studies and encourage others to do so as well. However, the available data on eight adult patients^16,17,19 suggest that the treatment of coagulation disorders does not confer a musculoskeletal benefit if it is initiated after the irreversible segmental collapse of the head of the femur (that is, when the patient has Ficat stage-III or IV involvement^14,15) but that treatment can confer dramatic symptomatic and radiographic benefits if it is initiated well before the irreversible death of bone (that is, when the patient has Ficat stage-I or II involvement^14,15). These findings emphasize the importance of the earliest possible diagnosis.

References

Introduction | Case Report | Discussion | References

Allaart, C. F.; Poort, S. R.; Rosendaal, F. R.; Reitsma, P. H.; Bertina, R. M.; and Briët, E.: Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect. Lancet,341: 134-138, 1993.341134 1993 [PubMed]

Boettcher, W. G.; Bonfiglio, M.; Hamilton, H. H.; Sheets, R. F.; and Smith, K.: Non-traumatic necrosis of the femoral head. Part I. Relation of altered hemostasis to etiology. J. Bone and Joint Surg.,52-A: 312-321, March 1970.52-A312 1970

Bokarewa, M. I.; Blomback, M.; Egberg, N.; and Rosen, S.: A new variant of interaction between phospholipid antibodies and the protein C system. Blood Coag. and Fibrinol.,5: 37-41, 1994.537 1994

Cecil, M. L.; Fenton, P. J.; and Jackson, W. T.: The perioperative management of protein S deficiency in total hip arthroplasty. Clin. Orthop.,303: 170-172, 1994.303170 1994 [PubMed]

Choi, I. H.; Lee, D. Y.; Chung, C. Y.; Rhyu, K. H.; and Park, S. Y.: Changes in coagulation-fibrinolysis system in Legg-Perthes disease: a preliminary report [abstract]. Proc. Pediat. Orthop. Soc. North America,10: 315, 1995.10315 1995

Comp, P. C.: Laboratory evaluation of protein S status. Sem. Thromb. and Hemost.,16: 177-181, 1990.16177 1990

Comp, P. C., and Esmon, C. T.: Recurrent venous thromboembolism in patients with a partial deficiency of protein S. New England J. Med.,311: 1525-1528, 1984.3111525 1984

Comp, P. C.; Doray, D.; Patton, D.; and Esmon, C. T.: An abnormal plasma distribution of protein S occurs in functional protein S deficiency. Blood,67: 504-508, 1986.67504 1986 [PubMed]

Comp, P. C.; Nixon, R. R.; Cooper, M. R.; and Esmon, C. T.: Familial protein S deficiency is associated with recurrent thrombosis. J. Clin. Invest.,74: 2082-2088, 1984.742082 1984 [PubMed]

Comp, P. C.; Thurnau, G. R.; Welsh, J.; and Esmon, C. T.: Functional and immunologic protein S levels are decreased during pregnancy. Blood,68: 881-885, 1986.68881 1986 [PubMed]

Dahlback, B.: Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism. Blood,85: 607-614, 1995.85607 1995 [PubMed]

Dahlback, B., and Stenflo, J.: High molecular weight complex in human plasma between vitamin K-dependent protein S and complement component C4b-binding protein. Proc. Nat. Acad. Sci.,78: 2512-2516, 1981.782512 1981 [PubMed]

Engesser, L.; Broekmans, A. W.; Briät, E.; Brommer, E. J.; and Bertina, R. M.: Hereditary protein S deficiency: clinical manifestations. Ann. Intern. Med.,106: 677-682, 1987.106677 1987 [PubMed]

Ficat, R. P.: Idiopathic bone necrosis of the femoral head. Early diagnosis and treatment. J. Bone and Joint Surg.,67-B(1): 3-9, 1985.67-B(1)3 1985

Ficat, R. P., and Arlet, J.: Functional investigation of bone under normal conditions. In Ischemia and Necroses of Bone, pp. 29-52. Edited by D. S. Hungerford. Baltimore, Williams and Wilkins, 1980.

Glueck, C. J.; Freiberg, R.; Tracy, T.; and Wang, P.: Thrombophilia, hypofibrinolysis, and reversible osteonecrosis [abstract]. J. Invest. Med.,44: 357A, 1996.44357 1996

Glueck, C. J.; Freiberg, R.; Tracy, T.; Stroop, D.; and Wang, P.: Thrombophilia and hypofibrinolysis. Pathophysiologies of osteonecrosis. Clin. Orthop.,334: 43-56, 1997.33443 1997 [PubMed]

Glueck, C. J.; Crawford, A.; Roy, D.; Freiberg, R.; Glueck, H.; and Stroop, D.: Association of antithrombotic factor deficiencies and hypofibrinolysis with Legg-Perthes disease. J. Bone and Joint Surg.,78-A: 3-13, Jan. 1996.78-A3 1996

Glueck, C. J.; Freiberg, R.; Glueck, H. I.; Tracy, T.; Stroop, D.; and Wang, Y.: Idiopathic osteonecrosis, hypofibrinolysis, high plasminogen activator inhibitor, high lipoprotein(a) and therapy with stanozolol. Am. J. Hematol.,48: 213-220, 1995.48213 1995 [PubMed]

Glueck, C. J.; Glueck, H. I.; Tracy, T.; Speirs, J.; McCray, C.; and Stroop, D.: Relationships between lipoprotein(a), lipids, apolipoproteins, basal and stimulated fibrinolytic regulators, and d-dimer. Metabolism,42: 236-246, 1993.42236 1993 [PubMed]

Glueck, C. J.; McMahon, R. E.; Bouquot, J.; Stroop, D.; Tracy, T.; Wang, P.; and Rabinovich, B.: Thrombophilia, hypofibrinolysis, and alveolar osteonecrosis of the jaws. Oral Surg., Oral Med., Oral Pathol., Oral Radiol., and Endodont.,81: 557-566, 1996.81557 1996

Glueck, C. J.; Glueck, H. I.; Greenfield, D.; Freiberg, R.; Kahn, A.; Hamer, T.; Stroop, D.; and Tracy, T.: Protein C and S deficiency, thrombophilia and hypofibrinolysis; pathophysiologic causes of Legg-Perthes disease. Pediat. Res.,35: 383-388, 1994.35383 1994 [PubMed]

Glueck, C. J.; McMahon, R. E.; Bouquot, J. E.; Stroop, D.; Tracy, T.; Freiberg, R.; Wang, Y.; and Rabinovich, B.: The pathophysiology of idiopathic osteonecrosis of the jaws: thrombophilia and hypofibrinolysis [abstract]. J. Invest. Med.,43 (Supplement 2): 234A, 1995.43 (Supplement 2)234 1995

Glueck, C. J.; Freiberg, R.; Glueck, H. I.; Henderson, C.; Welch, M.; Tracy, T.; Stroop, D.; Hamer, T.; Sosa, F.; and Levy, M.: Hypofibrinolysis: a common, major cause of osteonecrosis. Am. J. Hematol.,45: 156-166, 1994.45156 1994 [PubMed]

Goldhaber, S. Z.: Prevention of Venous Thromboembolism, pp. 3-24. New York, Marcel Dekker, 1993.

Griffin, J. H.; Evatt, B.; Zimmerman, T. S.; Kleiss, A. J.; and Wideman, C.: Deficiency of protein C in congenital thrombotic disease. J. Clin. Invest.,68: 1370-1373, 1981.681370 1981 [PubMed]

Gruppo, R.; Glueck, C. J.; McMahon, R. E.; Bouquot, J.; Rabinovich, B. A.; Becker, A.; Tracy, T.; and Wang, P.: Anticardiolipin antibodies, thrombophilia, and hypofibrinolysis. J. Lab. and Clin. Med.,127: 481-489, 1996.127481 1996

Hamilton, H. E.; Bonfiglio, M.; Sheets, R. F.; and Connor, W. E.: Relation of altered hemostasis to idiopathic aseptic necrosis of the femoral head [abstract]. J. Clin. Invest.,44: 1058, 1965.441058 1965

Heijboer, H.; Brandjes, D. P.; Buller, H. R.; Sturk, A.; and ten Cate, J. W.: Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. New England J. Med.,323: 1512-1516, 1990.3231512 1990

Hungerford, D. S., and Lennox, D. W.: Diagnosis and treatment of ischemic necrosis of the femoral head. In Surgery of the Musculoskeletal System , edited by C. McC. Evarts. Ed. 2, vol. 3, pp. 2757-2794. New York, Churchill Livingstone, 1990.

Hungerford, D. S., and Zizic, T. M.: The treatment of ischemic necrosis of bone in systemic lupus erythematosus. Medicine,59: 143-148, 1980.59143 1980 [PubMed]

Jones, J. P., Jr.: Etiology and pathogenesis of osteonecrosis. Sem. Arthroplasty,2: 160-168, 1991.2160 1991

Jones, J. P., Jr.: Intravascular coagulation and osteonecrosis. Clin. Orthop.,277: 41-53, 1992.27741 1992 [PubMed]

Mankin, H. J.: Nontraumatic necrosis of bone (osteonecrosis). New England J. Med.,326: 1473-1479, 1992.3261473 1992

Mont, M. A., and Hungerford, D. S.: Current concepts review. Non-traumatic avascular necrosis of the femoral head. J. Bone and Joint Surg.,77-A: 459-474, March 1995.77-A459 1995

Mont, M. A.; Fairbank, A. C.; Petri, M.; and Hungerford, D. S.: Core decompression for osteonecrosis of the femoral head in systemic lupus erythematosus. Clin. Orthop.,334: 91-97, 1997.33491 1997 [PubMed]

Nilsson, I. M.; Krook, H.; Sternby, N.-H.; Söderberg, E.; and Söderström, N.: Severe thrombotic disease in a young man with bone marrow and skeletal changes and with a high content of an inhibitor in the fibrinolytic system. Acta Med. Scandinavica,169: 323-337, 1961.169323 1961

Ohzono, K.; Saito, M.; Sugano, N.; Takaoka, K.; and Ono, K.: The fate of nontraumatic avascular necrosis of the femoral head. A radiologic classification to formulate prognosis. Clin. Orthop.,277: 73-78, 1992.27773 1992 [PubMed]

Ono, K., and Sugioka, Y.: Epidemiology and risk factors in avascular osteonecrosis of the femoral head. In Bone Circulation and Vascularization in Normal and Pathological Conditions, pp. 243-248. Edited by A. Schoutens, J. Arlet, J. W. M. Gardeniers, and S. P. F. Hughes. New York, Plenum Press, 1993.

Proby, C. M.; Chitolie, A.; Bevan, D. H.; and Mortimer, P. S.: Cutaneous necrosis associated with protein S deficiency. J. Roy. Soc. Med.,83: 646-647, 1990.83646 1990 [PubMed]

Rickles, F. R., and O'Leary, D. S.: Role of coagulation system in pathophysiology of sickle cell disease. Arch. Intern. Med.,133: 635-641, 1974.133635 1974 [PubMed]

Robinow, M.; Johnson, G. F.; Nanagas, M. T.; and Mesghali, H.: Skeletal lesions following meningococcemia and disseminated intravascular coagulation. A recognizable skeletal dystrophy. Am. J. Dis. Child.,137: 279-281, 1983.137279 1983 [PubMed]

Schafer, A. I.: The hypercoagulable states. Ann. Intern. Med.,102: 814-828, 1985.102814 1985 [PubMed]

Seleznick, M. J.; Silveira, L. H.; and Espinoza, L. R.: Avascular necrosis associated with anticardiolipin antibodies. J. Rheumatol.,18: 1416-1417, 1991.181416 1991 [PubMed]

Stulberg, B. N.: Osteonecrosis. In Orthopaedic Knowledge Update. Hip and Knee Reconstruction, pp. 87-96. Edited by J. J. Callaghan, D. A. Dennis, W. G. Paprosky, and A. G. Rosenberg. Rosemont, Illinois, The American Academy of Orthopaedic Surgeons, 1995.

Van Veldhuizen, P. J.; Neff, J.; Murphey, M. D.; Bodensteiner, D.; and Skikne, B. S.: Decreased fibrinolytic potential in patients with idiopathic avascular necrosis and transient osteoporosis of the hip. Am. J. Hematol.,44: 243-248, 1993.44243 1993 [PubMed]

Wilkes, C. H., and Visscher, M. B.: Some physiological aspects of bone marrow pressure. J. Bone and Joint Surg.,57-A: 49-57, Jan. 1975.57-A49 1975

Zizic, T. M., and Hungerford, D. S.: Avascular necrosis of bone. In Textbook of Rheumatology, edited by W. N. Kelley, E. D. Harris, Jr., S. Ruddy, and C. B. Sledge. Ed. 2, vol. 2, pp. 1689-1710. Philadelphia, W. B. Saunders, 1985.

Zizic, T. M.; Hungerford, D. S.; and Stevens, M. B.: Ischemic bone necrosis in systemic lupus erythematosus. II. The early diagnosis of ischemic necrosis of bone. Medicine,59: 134-142, 1980.59134 1980 [PubMed]

Topics